A Phase 2b Study of Modified Vaccinia Virus to Treat Patients Advanced Liver Cancer Who Failed Sorafenib

NCT01387555 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

129

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatocellular Carcinoma
Liver Cancer
HCC

Interventions

BIOLOGICAL: JX-594 recombinant vaccina GM-CSF
OTHER: Best Supportive Care

Sponsor

Jennerex Biotherapeutics